SOLVENTUM CORPORATION (SOLV) EBITDA
- 2026-06-30: Basis Reported; EBITDA $314.00M*; Operating income $181.00M; Depreciation and amortization $133.00M*.
- 2026-03-31: Basis Reported; EBITDA $216M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA $241M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA $1.81B*; Operating income $1.69B; Depreciation and amortization $121.00M*.
Complete source-backed ebitda history.
- Available history
- 2022-12-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | $314.00M* | $181.00M | $133.00M* | (m) | (m) | $83.00M* | $227.00M* | (m) | $178.00M | $927.00M | $15.00M |
|---|
| 2026-03-31 | Reported | $216M | (m) | (m) | (m) | 10.76% | $84.00M | -$189.00M | (m) | $189.00M | $827.00M | $3.00M |
|---|
| 2025-12-31 | Reported | $241M | (m) | (m) | (m) | 12.06% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | $1.81B* | $1.69B | $121.00M* | (m) | (m) | $97.00M* | $76.00M* | (m) | $183.00M | $780.00M | $248.00M |
|---|
| 2025-06-30 | Reported | $336.00M* | $214.00M | $122.00M* | (m) | (m) | $110.00M* | $169.00M* | (m) | $189.00M | $772.00M | $13.00M |
|---|
| 2025-03-31 | Reported | $281M | (m) | (m) | (m) | 13.57% | $109.00M | $29.00M | (m) | $193.00M | $769.00M | -$99.00M |
|---|
| 2024-12-31 | Reported | $286M | (m) | (m) | (m) | 13.78% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | $408.00M* | $275.00M | $133.00M* | (m) | (m) | $93.00M* | $169.00M* | (m) | $189.00M | $701.00M | $45.00M |
|---|
| 2024-06-30 | Reported | $377.00M* | $244.00M | $133.00M* | (m) | (m) | $58.00M* | $355.00M* | (m) | $192.00M | $701.00M | $7.00M |
|---|
| 2024-03-31 | Reported | $520M | (m) | (m) | (m) | 25.79% | $102.00M | $442.00M | (m) | $195.00M | $596.00M | $92.00M |
|---|
| 2023-12-31 | Reported | $545M | (m) | (m) | (m) | 26.77% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | $648.00M* | $504.00M | $144.00M* | (m) | (m) | $66.00M* | $493.00M* | (m) | $180.00M | $525.00M | $40.00M |
|---|
| 2023-06-30 | Reported | $550.00M* | $417.00M | $133.00M* | (m) | (m) | $71.00M* | $366.00M* | (m) | $193.00M | $579.00M | $92.00M |
|---|
| 2023-03-31 | Reported | $510M | (m) | (m) | (m) | 25.36% | $65.00M | $509.00M | (m) | $195.00M | $577.00M | $70.00M |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | $2.67B | (m) | (m) | (m) | 32.07% | $379.00M | $369.00M | (m) | $739.00M | $3.08B | $157.00M |
|---|
| 2024-12-31 | Reported | $1.59B | (m) | (m) | (m) | 19.28% | $380.00M | $1.19B | (m) | $775.00M | $2.78B | $127.00M |
|---|
| 2023-12-31 | Reported | $2.25B | (m) | (m) | (m) | 27.49% | $290.00M | $1.92B | (m) | $758.00M | $2.30B | $321.00M |
|---|
| 2022-12-31 | Reported | $2.27B | (m) | (m) | (m) | 27.93% | $251.00M | $1.68B | (m) | $767.00M | $2.23B | $349.00M |
|---|